A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne

NCT06415305 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Winlevi (clascoterone) 1% cream

Sponsor

Sun Pharmaceutical Industries Limited